Form 4 · BMY
Bristol Myers Squibb Chief Commercial Officer Adam Lenkowsky reports exercising or converting 7,522 shares
Part of a grouped insider digest: see all related filings with totals →
Adam Lenkowsky, Bristol Myers Squibb's EVP, Chief Commercial Officer, filed a Form 4 on Nov 4, 2026 at 4:49 PM ET reporting transactions on Nov 3, 2026.
The filing reports 7,522 shares in an exercise or conversion of a derivative security (code M); and 3,848 shares withheld to pay the exercise price or tax (code F).
After these transactions, the filing lists 23,380 shares of Common Stock, $0.10 par value held directly.
Effect on holdings
Taken together, the rows reported here raised Adam Lenkowsky's directly held shares by 18.6%, from 19,706 to 23,380.
Reporting person
- Adam Lenkowsky, EVP, Chief Commercial Officer (as filed: Lenkowsky Adam)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-03 | M | Common Stock, $0.10 par value | 7,522 | Acquired | 27,228 | Direct | |
| 2026-11-03 | F | Common Stock, $0.10 par value | 3,848 | $61.71 | Disposed | 23,380 | Direct |
| 2026-11-03 | M | Restricted Stock Units (derivative) | 7,522 | Disposed | 15,046 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 4, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Bristol Myers Squibb company file → · More Bristol Myers Squibb filings
Disclosures
- Editor holdings in BMY
- The editor holds no position in Bristol Myers Squibb (BMY). As of Nov 11, 2026.
- Last updated
- Nov 4, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold BMY.